87 related articles for article (PubMed ID: 2945927)
1. Measurements of androgenicity. The spectrum of progestogen activity.
Batzer FR
J Reprod Med; 1986 Sep; 31(9 Suppl):848-64. PubMed ID: 2945927
[TBL] [Abstract][Full Text] [Related]
2. [Differentiated application of oral contraceptives basing on the different side effects of synthetic progestins (author's transl)].
Braendle W; Leidenberger F
Ther Umsch; 1976 Apr; 33(4):231-3. PubMed ID: 137547
[TBL] [Abstract][Full Text] [Related]
3. Formulation and noncontraceptive uses of the new, low-dose oral contraceptive.
Batzer FR
J Reprod Med; 1984 Jul; 29(7 Suppl):503-12. PubMed ID: 6237195
[TBL] [Abstract][Full Text] [Related]
4. Drospirenone: a novel progestogen with antimineralocorticoid and antiandrogenic activity.
Muhn P; Fuhrmann U; Fritzemeier KH; Krattenmacher R; Schillinger E
Ann N Y Acad Sci; 1995 Jun; 761():311-35. PubMed ID: 7625729
[TBL] [Abstract][Full Text] [Related]
5. Development of diabetes mellitus and hypertension due to aggravation of insulin resistance after estrogen--progestogen in HAIR-AN syndrome.
Vaidya RA; Shringi MS; Vaidya AB; Gogate JG
J Assoc Physicians India; 1997 Nov; 45(11):883-4. PubMed ID: 11229194
[No Abstract] [Full Text] [Related]
6. The pharmacology of progestogens.
Brenner PF
J Reprod Med; 1982 Aug; 27(8 Suppl):490-7. PubMed ID: 6890111
[No Abstract] [Full Text] [Related]
7. [An introduction to synthetic progestogens pharmacology (author's transl)].
Raynaud JP; Bercovici JP
Ann Endocrinol (Paris); 1979; 40(3 Suppl):300-20. PubMed ID: 386914
[TBL] [Abstract][Full Text] [Related]
8. Effects on acne of two oral contraceptives containing desogestrel and cyproterone acetate.
Charoenvisal C; Thaipisuttikul Y; Pinjaroen S; Krisanapan O; Benjawang W; Koster A; Doesburg W
Int J Fertil Menopausal Stud; 1996; 41(4):423-9. PubMed ID: 8894800
[TBL] [Abstract][Full Text] [Related]
9. [Pharmacology of progestins].
Michel G; Kuttenn F
Rev Prat; 1981 Apr; 31(19):1333-47. PubMed ID: 7233015
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of an oral contraceptive containing EE 0.03 mg and CMA 2 mg (Belara) in moderate acne resolution: a randomized, double-blind, placebo-controlled Phase III trial.
Plewig G; Cunliffe WJ; Binder N; Höschen K
Contraception; 2009 Jul; 80(1):25-33. PubMed ID: 19501212
[TBL] [Abstract][Full Text] [Related]
11. [Rationale for prescribing oral contraceptives].
Teichmann AT
Wien Med Wochenschr; 1998; 148(7):171-4. PubMed ID: 9700865
[TBL] [Abstract][Full Text] [Related]
12. [Progestogens].
Irahara M; Matsuzaki T; Kuwahara A; Yasui T
Nihon Rinsho; 2008 Jan; 66(1):111-6. PubMed ID: 18193550
[TBL] [Abstract][Full Text] [Related]
13. The antiandrogens. When and how they should be used.
Sawaya ME; Hordinsky MK
Dermatol Clin; 1993 Jan; 11(1):65-72. PubMed ID: 8435919
[TBL] [Abstract][Full Text] [Related]
14. Yasmin: the reason why.
Thorneycroft IH
Eur J Contracept Reprod Health Care; 2002 Dec; 7 Suppl 3():13-8; discussion 42-3. PubMed ID: 12659402
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of hirsutism and acne. Sequential inverse therapy with anti-androgen-estrogen].
Lebeau M; Vokaer R
J Gynecol Obstet Biol Reprod (Paris); 1972; 1(7):715-21. PubMed ID: 4267704
[No Abstract] [Full Text] [Related]
16. [Acne and oral contraceptives].
van der Meeren HL; Hamerlynck JV; van der Hurk CM
Ned Tijdschr Geneeskd; 1984 Jul; 128(28):1333-7. PubMed ID: 6237266
[No Abstract] [Full Text] [Related]
17. Effects of dydrogesterone and norethisterone, in combination with oestradiol, on lipoproteins and inflammatory markers in postmenopausal women.
Kwok S; Charlton-Menys V; Pemberton P; McElduff P; Durrington PN
Maturitas; 2006 Mar; 53(4):439-46. PubMed ID: 16139447
[TBL] [Abstract][Full Text] [Related]
18. The pharmacological profile of TX 066 (17 alpha-acetoxy-6-methyl-19-nor-4,6-pregna-diene-3,20-dione), a new oral progestative.
Paris J; Thévenot R; Bonnet P; Granero M
Arzneimittelforschung; 1983; 33(5):710-5. PubMed ID: 6683550
[TBL] [Abstract][Full Text] [Related]
19. [Management of virilization with an antiandrogen-containing contraceptive].
Apró G; Sas M
Orv Hetil; 1981 Jul; 122(30):1821-4. PubMed ID: 6458007
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of the polycystic ovary syndrome (author's transl)].
Buvat J; Buvat-Herbaut M
Nouv Presse Med; 1981 May; 10(24):2019-23. PubMed ID: 7255138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
